Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease

The discouraging results with therapies for Alzheimer’s disease (AD) in clinical trials, highlights the urgent need to adopt new approaches. Like other complex diseases, it is becoming clear that AD therapies should focus on the simultaneous modulation of several targets implicated in the disease. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuadrado-Tejedor, Mar, Pérez-González, Marta, García-Muñoz, Cristina, Muruzabal, Damián, García-Barroso, Carolina, Rabal, Obdulia, Segura, Víctor, Sánchez-Arias, Juan A., Oyarzabal, Julen, Garcia-Osta, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597953/
https://www.ncbi.nlm.nih.gov/pubmed/31281249
http://dx.doi.org/10.3389/fnagi.2019.00149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597953/
https://www.ncbi.nlm.nih.gov/pubmed/31281249
http://dx.doi.org/10.3389/fnagi.2019.00149

Ejemplares similares